medical and pharmaceutical translations

Choosing a trusted vendor is essential in medical and pharmaceutical translations, which often use highly specialized language and include sensitive data. KONTEKST is a certified vendor of life science translations. We are proud to be working with national regulatory authorities, such as the European Medicines Agency , which proves our reliability as a linguistic service provider.
We have been present on the market for more than 20 years. This has allowed us to acquire vast experience delivering projects for leading companies in the field of medicine, pharmacy, biotechnology, dental and veterinary medicine, clinical studies and medical devices. We provide highly specialized medical translations in 250 language combinations!
Thanks to our advanced quality management system and continuous monitoring of our clients’ needs, KONTEKST is able to provide professional translations in all European and Asian languages. Each translation project, however straightforward, includes a proofreading service, which ensures linguistic and terminological consistency and makes all our medical translations reliable, letting KONTEKST enjoy an excellent reputation as a medical translation vendor.

We offer tailor-made solutions for medical and pharmaceutical companies:

Medical translations are prepared by medical doctors, academics with relevant experience, as well as translators with medical, pharmaceutical or biotech educational background. All translations are proofread. This is to ensure all our translations are fully accurate and consistent with the original language content. In addition, which is especially important in the medical and pharmaceutical industry, we operate in compliance with the GDPR and our own data privacy procedures.

Medical and pharmaceutical translation and interpreting are our main fields of specialty

Ischemic heart disease, colorectal cancer, breast cancer, cerebrovascular disorders and pneumonia are among the most dangerous modern-day diseases, according to data from the Statistical Office of the European Union. Eurostat’s data imply a pressing need for conducting clinical trials in the fields of cardiology, oncology, neurology and respiratory medicine, and pose a challenge to the pharmaceutical industry.

The European Medicines Agency (EMA) names anticoagulants, antihemorrhagic agents and immunosuppressants among the medicinal products subject to continuous supervision and research. Before being placed on the market, every medicine must also be [subject to clinical trials] approved by regulatory authorities and an Ethics Committee . These types of trials include a number of phases and require appropriate medical records to be kept.

Due to the global scale of these studies, the records must be translated into various languages. At KONTEKST, we work with many CROs, assisting them with the translation of documents such as study protocols, reports or clinical trial agreements. English is the dominant language in this context. However, since some of the documents are also addressed directly to patients who participate in the study, they must be written in their mother tongues. For this reason, KONTEKST is also experienced in translating documents such as: informed consent forms and patient cards, diaries or instructions.

Once a medicinal product is successfully placed on the market, it is important to reach as wide a target audience as possible. To ensure that, we work with medical and pharmaceutical companies, translating drug manufacturing technology descriptions, labels, patient leaflets and brochures, legal acts regulating the medical and pharmaceutical market, research papers and publications, as well as promotional materials.